Published in Nature Biotechnology
Initiatives to gather massive epidemiological datasets aim to cut through national COVID-19 stats in a bid to understand the new coronavirus and aid public health policymakers.
Published in Nature Biotechnology
The interaction between patents and FDA’s De Novo and 510(k) regulatory pathways has the potential to threaten follow-on innovation for medical devices.
Published in Nature Biotechnology
A new workshop brings together under-represented participants to gain experience working in diverse teams, identifying problems worth solving, and learning evidence-based entrepreneurship approaches.
Published in Nature Biotechnology
Four antibodies are already in trials to test efficacy against the emerging checkpoint molecule TIGIT, but debate swirls around the importance of Fc binding for drug action.
Published in Nature Biotechnology
A deep brain stimulation device capable of fine-tuning output on the basis of patient neuronal activity has been approved for the first time for use in Parkinson’s and a range of other neurological disorders.
Published in Nature Biotechnology
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Published in Nature Biotechnology
The biological activities of >800,000 small molecules are represented within a uniform framework.
Published in Nature Biotechnology
Markers that distinguish pancreatic and hepatic progenitors improve stem-cell differentiation to pancreatic β cells.
Published in Nature Biotechnology
Viscoplastic electronic devices adapt as nerves enlarge in growing animals.
Published in Nature Biotechnology
A sex-distorter gene drive causes population collapse in the malaria mosquito.
